Abstract
In the present review, we provide a comprehensive summary of recent pharmacological studies on dopamine transporter (DAT) inhibitors, which are potential treatments for neurodegenerative and psychiatric disorders. Extensive structure-activity relationship studies have identified numerous tropane-based ligands with high affinity and selectivity for the DAT or with high affinity to the DAT and other monoamine transporters (dual and triple monoamine reuptake inhibitors). The review covers advances in the field in past fifteen years. Among the described compounds, many appear to be promising drug candidates, while other may serve as valuable tools for research or as prototypes for new classes of selective DAT inhibitors. Special attention is being paid to separation of the DAT inhibition from NET and SERT inhibition.
Keywords: ADHD, cocaine abuse, depression, dopamine transporter inhibitor, monoamine transporter inhibitor, tropane derivatives.
Current Medicinal Chemistry
Title:Progress in the Search for New Dopamine Transporter Inhibitors
Volume: 22 Issue: 28
Author(s): Beata Gryzlo, Paula Zareba, Katarzyna Malawska, Anna Jakubowska and Katarzyna Kulig
Affiliation:
Keywords: ADHD, cocaine abuse, depression, dopamine transporter inhibitor, monoamine transporter inhibitor, tropane derivatives.
Abstract: In the present review, we provide a comprehensive summary of recent pharmacological studies on dopamine transporter (DAT) inhibitors, which are potential treatments for neurodegenerative and psychiatric disorders. Extensive structure-activity relationship studies have identified numerous tropane-based ligands with high affinity and selectivity for the DAT or with high affinity to the DAT and other monoamine transporters (dual and triple monoamine reuptake inhibitors). The review covers advances in the field in past fifteen years. Among the described compounds, many appear to be promising drug candidates, while other may serve as valuable tools for research or as prototypes for new classes of selective DAT inhibitors. Special attention is being paid to separation of the DAT inhibition from NET and SERT inhibition.
Export Options
About this article
Cite this article as:
Gryzlo Beata, Zareba Paula, Malawska Katarzyna, Jakubowska Anna and Kulig Katarzyna, Progress in the Search for New Dopamine Transporter Inhibitors, Current Medicinal Chemistry 2015; 22 (28) . https://dx.doi.org/10.2174/0929867322666150812145631
DOI https://dx.doi.org/10.2174/0929867322666150812145631 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNA: Novel Modulators of the Cholinergic Anti-Inflammatory Pathway
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Endocrine Regulation of Stem Cells: Physiological Importance and Pharmacological Potentials for Cell-Based Therapy
Current Stem Cell Research & Therapy NO Chimeras as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Targeting T-Cell Adhesion Molecules for Drug Design
Current Pharmaceutical Design Progress on the Biological Activities of Helicid and its Derivatives
Current Organic Chemistry Design of Iodine-Lithium-α-Dextrin Liquid Crystal with Potent Antimicrobial and Anti-Inflammatory Properties
Current Pharmaceutical Design Training Pediatric Residents for Intervention on Tobacco
Current Pediatric Reviews Targeting CXCR4 in HIV Cell-Entry Inhibition.
Mini-Reviews in Medicinal Chemistry TRAIL: A Sword for Killing Tumors
Current Medicinal Chemistry An Updated Patent Review on Ocular Drug Delivery Systems with Potential for Commercial Viability
Recent Patents on Drug Delivery & Formulation Mouse Models of Autoimmune Diseases: Immune Thrombocytopenia
Current Pharmaceutical Design Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
Current Neuropharmacology Heavy Metal Toxicity in Humans and its Preventive and Control Measures
Current Nutrition & Food Science Alzheimers Disease Drug Development: Old Problems Require New Priorities
CNS & Neurological Disorders - Drug Targets Neurophysiological Alterations in the Prepsychotic Phases
Current Pharmaceutical Design Co-Induction of CYP3A12 and 3A26 in Dog Liver Slices by Xenobiotics: Species Difference Between Human and Dog CYP3A Induction
Drug Metabolism Letters Multi-Target Mining of Alzheimer Disease Proteome with Hansch’s QSBR-Perturbation Theory and Experimental-Theoretic Study of New Thiophene Isosters of Rasagiline
Current Drug Targets Anaesthetic Drugs: Linking Molecular Actions to Clinical Effects
Current Pharmaceutical Design Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions
Current Pharmaceutical Design Opioid Receptors and their Ligands
Current Topics in Medicinal Chemistry